MicroRNAs regulate skin Langerhans cells
MicroRNAs regulate skin Langerhans cells
批准号:
10006075
负责人:
Li Zhou
金额:
$33.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-08-31
关键词:
AdultAffectBioinformaticsBiologyBirthC-Type LectinsCandida albicansCell CountCell OntogenyCell physiologyCodeDefectDendritic CellsDermatitisDevelopmentDicer EnzymeDiseaseEmbryoEmbryonic DevelopmentEstrogen receptor positiveFetal LiverGene ExpressionGene Expression ProfileGenesGenetic TranslationGoalsGrowthHomeostasisITGAX geneImiquimodImmuneImmune ToleranceIndividualInfectionInflammationInflammatoryInterruptionInterventionKnock-in MouseLaboratoriesLangerhans cellLife Cycle StagesLinkMacrophage Colony-Stimulating Factor ReceptorMaintenanceMediatingMessenger RNAMicroRNAsModelingMolecularMonitorMusMutant Strains MiceMutationMyelogenousOutcomePathway interactionsProceduresProductionProteinsPsoriasisRegulationReportingResearchRibonuclease IIIRoleSignal PathwaySkinSmall RNAT cell differentiationT-Cell ProliferationTechnologyTestingTranslationsUntranslated RNAValidationYolk Sacadaptive immunityantigen-specific T cellsbaseblastomere structurecytokineexperienceinsightlangerinmacrophagemiRNA expression profilingmigrationmonocytemouse modelmutantnovelself-renewalsingle-cell RNA sequencingskin disordertranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Langerhans cells (LCs), the skin residing dendritic cells (DCs), control both the induction of
adaptive immunity, and immune tolerance in skin and are involved in variety of skin disease
development. However, the regulatory mechanisms involved in the development and functions
of LCs have not been completely elucidated. MicroRNAs (miRNAs), a class of non-coding small
RNAs, are recognized as important regulators of protein-coding genes through the inhibition of
mRNA translation. Using Cre-loxP Dicer deletion mouse models, our laboratory and others have
reported that deletion of miRNAs by CD11c-Cre or hLangerin-Cre significantly reduced the
number and interrupted the function of LCs, indicating that miRNAs are required for LC
homeostasis and function after birth. While there are more than 1000 experimentally reported
miRNAs, very few individual miRNAs are linked to LCs so far. We were the first to report that
miR-150 and miR-223 differentially regulated LC-induced T cell proliferation and cytokine
production. Most recently, our embryonic lineage-tracing studies showed that miRNAs, including
miR-17-92 cluster, regulate LC embryonic development. Furthermore, using miRNA arrays, we
identified that mature LCs have a unique miRNA gene expression profile compared to immature
LCs, and that miRNA expression is dynamically changed during LC embryonic ontogeny. These
findings led to our central hypothesis that the dynamically changed miRNAs may serve as
critical regulators controlling LC ontogeny, homeostasis and function through fine-tuning specific
target genes. In Aim 1, we will investigate the roles of miRNAs in LC ontogeny and homeostasis.
Constitutive or inducible Csf1r-specific individual miRNA mutant mice will be used for studying
embryonic LC ontogeny and LC repopulation after inflammation, while LC-specific Dicer or
individual miRNA mutant mice will be used for LC homeostasis after birth. In Aim 2, we will
investigate the roles of miRNAs in LC function, inducible LC-specific Dicer or individual miRNA
mutation mouse models will be used. In Aim 3, the direct target gene(s) of miRNAs and related
signaling pathways involved in LC development and function will be investigated by the
combination of RNA-seq, miRNA bioinformatics and related target functional validation
strategies. The proposed studies will uncover the dynamic miRNA-mRNA regulation and related
molecular mechanisms and signaling pathways that control LC development and function, which
will not only provide new insight into the biology of LCs, but may also facilitate the development
of LC-based intervention strategies for diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
-
批准号:10228607
-
项目类别:
-
资助金额:$69.75万
-
财政年份:2019
-
负责人:Li Zhou
-
依托单位:
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
-
批准号:10018800
-
项目类别:
-
资助金额:$69.62万
-
财政年份:2019
-
负责人:Li Zhou
-
依托单位:
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
-
批准号:10470022
-
项目类别:
-
资助金额:$70.25万
-
财政年份:2019
-
负责人:Li Zhou
-
依托单位:
MicroRNAs regulate skin Langerhans cells
-
批准号:10250383
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2018
-
负责人:Li Zhou
-
依托单位:
Improving Allergy Documentation and Clinical Decision Support in the EHR
-
批准号:9915842
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2018
-
负责人:Li Zhou
-
依托单位:
Encoding and Processing Patient Allergy Information in EHRs
-
批准号:8642929
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2013
-
负责人:Li Zhou
-
依托单位:
Encoding and Processing Patient Allergy Information in EHRs
-
批准号:8741955
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2013
-
负责人:Li Zhou
-
依托单位:
Integration of an NLP-based application to support medication management
-
批准号:8496045
-
项目类别:
-
资助金额:$14.82万
-
财政年份:2012
-
负责人:Li Zhou
-
依托单位:
Integration of an NLP-based application to support medication management
-
批准号:8354008
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2012
-
负责人:Li Zhou
-
依托单位:
Improving Outpatient Medication Lists Using Temporal Reasoning and Clinical Texts
-
批准号:7774682
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2009
-
负责人:Li Zhou
-
依托单位:
Improving Outpatient Medication Lists Using Temporal Reasoning and Clinical Texts
-
批准号:7935475
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2009
-
负责人:Li Zhou
-
依托单位:
海外基金